Skip to content
StockMarketAgent
Direct answer
PEP trades against a final fair-value range of $142.66-$206.45, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $143, high $206, with mid-point at $174.
Stock analysis

PEP PepsiCo Inc. fair value $174–$206

PEP
By StockMarketAgent.AI team· supervised by
Analysiert: 2026-05-08Nächste Aktualisierung: 2026-08-08Methodology v2.4Archetype: Mature dividendNASDAQ · Consumer Staples
View archive
Kurs
$154.62
▲ +19.79 (+12.80%)
Fair Value
$174
$174–$206
Rating
Kaufen
confidence 88/100
Aufwärtspotenzial
+12.8%
upside to fair value
Sicherheitsmarge
$148.25
buy below · 15%
Marktkapitalisierung
$211.4B
P/E fwd 16.9
Englische QuelleDE
Englische Quelle wird angezeigt, während wir übersetzen
Dieser Bericht wurde noch nicht übersetzt. Aktualisieren Sie in ein paar Minuten, sobald die Übersetzungswarteschlange aufgeholt hat.

§1 Zusammenfassung

  • Composite fair value $174 with high case $206.
  • Implied upside of 12.8% to fair value.
  • Moat 9/10 · confidence 88/100 · Mature dividend.
  • Trades at a measured discount to fair value with adequate margin of safety.
Fair value
$174
Margin of safety
+11.3%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$154.62Price
FV $174.41
High $206.45

PEP trades against a final fair-value range of $142.66-$206.45, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Deep global distribution networks covering
    Deep global distribution networks covering developed and emerging markets.
  • Immense brand equity and pricing
    Immense brand equity and pricing power across both beverage and snack portfolios.
  • Bull thesis
    Valuation synthesis intentionally anchors heavily on Forward Earnings to mitigate terminal value dominance.

§2 Bärenszenario

A sustained macroeconomic downturn coupled with accelerated adoption of GLP-1 weight-loss drugs leads to structural volume declines and an inability to offset cost inflation through pricing, heavily compressing operating margins and driving free cash flow below historical norms.

Wie diese These scheitern kann

GLP-1 Widespread Adoption

· Medium

Mass adoption of appetite-suppressing GLP-1 drugs permanently reduces per-capita consumption of high-calorie snacks and sugary beverages, breaking historical volume baselines.

FV impact
-25%
Trigger
3-5 years

Total Loss of Pricing Power

· Low

Consumer fatigue over successive price hikes forces aggressive discounting and promotional activity to defend market share against private label brands, destroying gross margins.

FV impact
-20%
Trigger
1-2 years

Supply Chain and Input Cost Shock

· Medium

Extreme agricultural commodity inflation and localized supply chain disruptions structurally elevate the cost base beyond what can be passed to consumers, permanently compressing operating margins.

FV impact
-15%
Trigger
1-3 years
Frühwarnsignale zur Überwachung
KennzahlAktuellAuslöseschwelle
Consecutive quarters of negative organic volume growth.MonitorDeterioration versus the report thesis
Gross margin compression exceeding 150 basis points.MonitorDeterioration versus the report thesis
Substantial shift in market share to private label brands.MonitorDeterioration versus the report thesis
Significant downward revisions in forward consensus earnings.MonitorDeterioration versus the report thesis
Unplanned increases in promotional spend to clear inventory.MonitorDeterioration versus the report thesis

§3 Finanzielle Historie

Gewinn- und Verlustrechnung — letzte sechs Perioden
PositionT−0T−1T−2T−3CAGR
Periode2022-12-312023-12-312024-12-312025-12-31Trend
Umsatz$86.39B$91.47B$91.85B$93.93B+2.8%
Bruttogewinn$45.82B$49.59B$50.11B$50.86B+3.5%
Betriebsergebnis$11.36B$12.91B$12.92B$13.49B+5.9%
Nettogewinn$8.91B$9.07B$9.58B$8.24B-2.6%
EPS (verwässert)$6.42$6.56$6.95$6.00-2.2%
EBITDA$14.92B$15.75B$16.68B$15.54B+1.4%
F&E
VVG$34.46B$36.68B$37.19B$37.37B+2.7%

Qualitäts-Scores

Piotroski F-Score
5 / 9
0–9 Qualitätskomposit
Altman Z-Score
3.59
Insolvenzrisiko (>3 sicher)
Beneish M-Score
-2.56
Risiko von Ergebnismanipulation
OCF / Nettogewinn
1.47×
>1 weist auf hohe Ergebnisqualität hin
Bilanzqualitätsschwelle
Pass
Sektoradjustierte Schwelle
ROIC
12.8%
Rendite auf eingesetztes Kapital
Abschnitt 3

Numbers analysis

Einzelabonnenten — ab §411 weitere Abschnitte

Vollständige Analyse lesen — 11 weitere Abschnitte.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Vollständiger Bericht für jeden abgedeckten Ticker
24 Monate Rating-Archiv
Watchlist-Briefings + Rating-Änderungs-Warnungen
PDF + DOCX Export in jeder Sprache
Kostenlose Testversion starten
Jederzeit kündbar.
FAQ

PEP — frequently asked questions

  1. Based on our latest analysis, PEP looks modestly undervalued. The current price is $155 versus a composite fair-value midpoint of $174 (range $143–$206), which implies roughly 12.8% upside to the midpoint.
Related coverage

Names readers of PEP also follow

Same archetype: mature-dividend
Same sector: Consumer Staples